Flagship Pioneering

Founded 2000
Founders Edwin Kania Noubar Afeyan

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 226
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 112
Rounds per year 10.76
Lead investments 35
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.53
Exits 58
Key employees 24
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
Summary

Flagship Pioneering appeared to be the VC, which was created in 2000. The main department of described VC is located in the Cambridge. The venture was found in North America in United States.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Manufacturing, Therapeutics. Among the various public portfolio startups of the fund, we may underline Moderna Therapeutics, Receptos, Indigo Agriculture The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The current fund was established by Edwin Kania, Noubar Afeyan. We also calculated 24 valuable employees in our database.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 8 percentage points more often commits exit comparing to other companies. The fund is constantly included in 7-12 deals per year. The top amount of exits for fund were in 2019. The top activity for fund was in 2009. The average startup value when the investment from Flagship Pioneering is more than 1 billion dollars. Comparing to the other companies, this Flagship Pioneering performs on 4 percentage points less the average number of lead investments.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Flagship Pioneering, startups are often financed by Kleiner Perkins, ARCH Venture Partners, OneLiberty Ventures. The meaningful sponsors for the fund in investment in the same round are Venrock, Third Rock Ventures, Khosla Ventures. In the next rounds fund is usually obtained by NanoDimension, Khosla Ventures, General Catalyst.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Flagship Pioneering:
Typical Co-investors
Flagship Pioneering is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Flagship Pioneering:

Funds with similar focus

Funds from United States, Cambridge
Funds with similar focus located in United States, Cambridge:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Laronde

Biotechnology
Medical
Therapeutics
1
$440M30 Aug 2021 United States, Cambridge

Ring Therapeutics

Biotechnology
Health Care
1
$117M28 Jul 2021 United States, Cambridge

Invaio Sciences

Agriculture
Biotechnology
Natural Resources
1
$88M25 May 2021 United States, Cambridge

Inari

Agriculture
AgTech
Biotechnology
Developer Platform
Embedded Systems
Environmental Engineering
Information Technology
Network Hardware
Security
1
$208M12 May 2021 United States, Cambridge

Laronde

Biotechnology
Medical
Therapeutics
1
$50M10 May 2021 United States, Cambridge

Repertoire Immune Medicines

Biotechnology
Life Science
Medical
Therapeutics
1
$189M13 Apr 2021 United States, Cambridge

Biotechnology
Health Care
1
$126M30 Mar 2021 United States, Cambridge

Cellarity

Biotechnology
Life Science
Pharmaceutical
1
$123M25 Feb 2021 United States, Cambridge

Tessera Therapeutics

Biopharma
Biotechnology
Therapeutics
1
$230M12 Jan 2021 United States, Cambridge
News
YourBio Health Raises $21M in Funding

– YourBio Health from Boston develops a personal health information company, raised $21M in funding.
– Series A round was led by Flagship Pioneering with participation from Newpath Partners.
– The company intends to use the funds to accelerate growth and support forthcoming product launches.

Laronde Raises $440M in Series B Financing

– Laronde is a Cambridge, Mass.-based company advancing Endless RNA™ (eRNA) – a novel, engineered form of RNA that can be programmed to express therapeutic proteins inside the body.
– The company raised $440m in Series B financing.
– The round was led by Flagship Pioneering, with participation from T. Rowe Price Associates, Inc., Invus, Canada Pension Plan Investment Board (CPP Investments), Fidelity Management & Research Company, funds and accounts managed by BlackRock, and Federated Hermes Kaufmann Funds, among others.
– The new investment will be used to advance the development of the company’s eRNA platform and a broad pipeline of programs across a number of therapeutic categories.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Flagship Pioneering?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: